Relation of calcitonin gene-related peptide to systemic vasodilatation and central hypovolaemia in cirrhosis

S Møller, F Bendtsen, S Schifter, Jens Henrik Sahl Henriksen

    35 Citations (Scopus)

    Abstract

    BACKGROUND: The aetiology of the reduced systemic vascular resistance and abnormal 'filling' of the vascular bed in cirrhosis is still obscure. As increased concentrations of the potent vasodilator calcitonin gene-related peptide (CGRP) have recently been reported in cirrhosis, we related CGRP to central and peripheral haemodynamics in patients with cirrhosis. METHODS: Thirty-one cirrhotic patients and six control subjects underwent an investigation with determination of systemic haemodynamics and circulating CGRP. RESULTS: Circulating CGRP was significantly increased in patients with cirrhosis (P < 0.02) and covaried directly with the severity of cirrhosis (P < 0.02). The increased CGRP covaried negatively with the reduced systemic vascular resistance (P < 0.02), the reduced central blood volume (P < 0.01), and reduced central circulation time (P < 0.002) and positively with the non-central blood volume (P < 0.05). CONCLUSIONS: These results suggest that increased CGRP may play a role in the systemic vasodilatation in cirrhosis and may contribute to the abnormal distribution of the blood volume, which may lead to abnormal sodium and water handling.
    Translated title of the contributionRelation of calcitonin gene-related peptide to systemic vasodilatation and central hypovolaemia in cirrhosis.
    Original languageEnglish
    JournalScandinavian Journal of Gastroenterology
    Volume31
    Issue number9
    Pages (from-to)928-933
    Number of pages6
    ISSN0036-5521
    Publication statusPublished - 1996

    Cite this